Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia greatly affects Greek women's daily life, relationships, and self-image, with mixed social support and dissatisfaction with treatments.

MK-0773 safely increased muscle mass but did not improve muscle strength or function in elderly women with sarcopenia.

Women with PCOS in North China often have hirsutism and acne, with hirsutism linked to metabolic issues.

Finasteride can cause lasting sexual, emotional, and cognitive issues, with varying severity.

Women with early hair loss have higher blood pressure and aldosterone; screening and treatment may help.

Women with PCOS have lower ghrelin levels and a weaker response to sugar, which might affect their feeling of fullness and lead to overeating.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

Women who had bariatric surgery risk nutritional deficiencies causing skin issues during pregnancy and breastfeeding.

Women with PCOS and polycystic ovaries have higher male hormone levels and more insulin resistance, especially if they are overweight.

Over one-third of women experience hair loss, with female-pattern hair loss being most common, and treatments include minoxidil and possibly hair transplantation.

Some birth control pills have a higher risk of blood clots than others.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

Many infertile women with PCOS in Central Vietnam have metabolic or insulin resistance syndrome, with obesity and older age increasing the risk.

MK-R7 supplement with Cistanche Tubulosa and Laminaria Japonica extracts improved hair density and scalp health without adverse effects.

Aging men face unique health issues like erectile dysfunction, prostate problems, and baldness.

Women with PCOS often have sleep problems, including sleep apnea, which are linked to obesity and depression.

Middle-aged women with chronic telogen effluvium experience increased hair shedding but usually don't get significantly thinner hair.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

Young Indian women with PCOS have a higher risk of heart disease, not linked to thyroid function but to higher levels of certain fats and homocysteine.

The conclusion is that individualized treatment and proper medication use are crucial in men's health, with specific recommendations for ED, BPH, and prostate cancer management.

Hormonal treatment in transgender women reduces semen quality, but stopping treatment may improve it.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

Epilepsy and certain epilepsy drugs can lead to reproductive problems in women, but changing medication might improve these issues.

The hepatitis B vaccine did not cause hair loss in the tested mice.

Proper education can prevent traction alopecia in women of color.

Treating excessive hair in women requires a holistic approach, including medical, aesthetic, and emotional support.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

New treatments for skin and hair disorders in women of color address unique biological differences and include specific acne medications, sunscreens, skin lighteners, and hair care adjustments.

Six African American women experienced hair loss after switching to a new HIV medication.